노로바이러스 진단 시장

Global Norovirus Diagnostics Market to Reach US$106.1 Million by 2030

The global market for Norovirus Diagnostics estimated at US$69.0 Million in the year 2024, is expected to reach US$106.1 Million by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Rapid Test Kits, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$68.3 Million by the end of the analysis period. Growth in the PCR Kits segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.1 Million While China is Forecast to Grow at 7.2% CAGR

The Norovirus Diagnostics market in the U.S. is estimated at US$18.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$17.0 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.9% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global Norovirus Diagnostics Market - Key Trends & Drivers Summarized

Why Is Demand for Norovirus Testing Increasing in Healthcare Settings?

Norovirus is one of the most common causes of viral gastroenteritis worldwide, affecting individuals across all age groups. Due to its high transmissibility, outbreaks often occur in hospitals, long-term care facilities, schools, and cruise ships. The need for timely and accurate diagnosis has increased as healthcare systems aim to reduce the spread of infection and manage outbreaks efficiently. Unlike other gastrointestinal illnesses, norovirus can spread quickly through contaminated surfaces, food, or water, making early identification critical.

Routine diagnostic practices now incorporate norovirus testing, especially for patients presenting with acute diarrhea in institutional settings. Clinicians increasingly require rapid, sensitive tools to differentiate norovirus from bacterial and other viral infections. The growing adoption of diagnostic testing in outpatient care and emergency settings reflects heightened clinical awareness and regulatory emphasis on infection control protocols.

How Are Diagnostic Technologies Evolving to Improve Speed and Accuracy?

Technological advancements are driving the shift from traditional enzyme immunoassays toward molecular diagnostics that offer greater sensitivity and specificity. Real-time PCR-based assays and multiplex panels are now widely used for detecting norovirus genogroups in stool samples. These platforms deliver rapid results, enabling healthcare providers to take timely preventive measures and initiate appropriate care.

Point-of-care testing devices are also emerging for decentralized use in clinics and care facilities, providing faster turnaround without the need for centralized labs. Improvements in assay design, sample preparation, and nucleic acid amplification are supporting reliable detection of low viral loads. Multiplex molecular tests that include norovirus along with other enteric pathogens are increasingly preferred in clinical workflows to streamline diagnosis in gastroenteritis cases.

What Institutional and Public Health Trends Are Expanding Testing Adoption?

Institutions such as hospitals, schools, and elder care centers are investing in routine norovirus screening protocols to reduce the impact of outbreaks. Public health agencies have implemented stricter guidelines for managing acute gastroenteritis in high-risk environments, contributing to more frequent diagnostic testing. Laboratories are adopting automated systems that allow high-throughput norovirus detection during peak seasons or in outbreak scenarios.

Global travel and food service industries also play a role, as foodborne and waterborne transmission drive demand for diagnostic surveillance. In response, food safety laboratories and environmental testing services are incorporating norovirus assays to meet compliance and quality control standards. Surveillance programs tracking genotypic variation and outbreak sources rely heavily on laboratory-confirmed norovirus cases, further integrating diagnostics into broader epidemiological monitoring systems.

Growth in the norovirus diagnostics market is driven by several factors.

Rising incidence of norovirus-related outbreaks in institutional and community settings is pushing demand for rapid and accurate diagnostic tools. Technological improvements in molecular testing, including real-time PCR and multiplex platforms, are enhancing detection speed and reliability. Increasing implementation of infection control protocols in hospitals, long-term care facilities, and schools is encouraging more consistent use of diagnostics. Expansion of point-of-care testing and high-throughput lab platforms is supporting faster outbreak response. Regulatory focus on food safety and public health surveillance is further driving adoption of norovirus diagnostics across healthcare, environmental, and food industry applications.

SCOPE OF STUDY:

The report analyzes the Norovirus Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Rapid Test Kits, PCR Kits, ELISA-based Kits); End-Use (Hospitals End-Use, Diagnostics Labs End-Use, Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• Abingdon Health
• Altona Diagnostics GmbH
• bioMerieux SA
• Becton, Dickinson and Company
• CerTest Biotec S.L.
• Danaher Corporation (Cepheid)
• DiaSorin S.p.A.
• ELITechGroup AG
• Eiken Chemical Co.
• Elisabeth Pharmacon
• Meridian Bioscience, Inc.
• Qiagen N.V.
• Quidel Corporation
• Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
• Seegene Inc.
• Thermo Fisher Scientific, Inc.
• Luminex Corporation
• Bio-Rad Laboratories, Inc.
• Hologic, Inc.
• GenMark Diagnostics, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Norovirus Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Outbreak Frequency Drives Demand for Rapid Point-of-Care Norovirus Testing
  • Expansion of On-Site Molecular Diagnostic Capabilities Strengthens Infection Control Measures
  • Increased Use of PCR and Isothermal Amplification Techniques Enhances Detection Accuracy
  • Growing Focus on Food Safety Regulations Propels Adoption of Norovirus Screening Tools
  • Demand for Self-Contained Test Kits in Travel and Hospitality Sectors Accelerates Market Growth
  • Integration of Multiplex Panels Throws the Spotlight on Concurrent GI Pathogen Testing
  • Rising Awareness of Norovirus Transmission via Surface Contamination Generates Demand for Environmental Testing
  • Advancements in Biosensor and Microfluidics Technologies Support Portable Testing Solutions
  • Growth in Institutional and Healthcare Facility Testing Spurs New Contracting Opportunities
  • Rising Adoption of High-Throughput Lab Systems Expands Capacity for Mass Screening
  • Focus on Improved Sample Prep and Viral Concentration Methods Drives Sensitivity Improvements
  • Investment in At-Home Diagnostic Kits Encourages Decentralized Norovirus Testing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Norovirus Diagnostics Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Norovirus Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Norovirus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Rapid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Rapid Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for PCR Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for PCR Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for ELISA-based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for ELISA-based Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Diagnostics Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Diagnostics Labs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 16: USA Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 17: USA 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 18: USA Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 19: USA 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• CANADA
  • TABLE 20: Canada Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Canada 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 22: Canada Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 23: Canada 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• JAPAN
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 24: Japan Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 25: Japan 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 26: Japan Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Japan 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• CHINA
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 28: China Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 29: China 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 30: China Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 31: China 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• EUROPE
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Norovirus Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: Europe 6-Year Perspective for Norovirus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 34: Europe Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 35: Europe 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 36: Europe Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 37: Europe 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• FRANCE
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: France 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 40: France Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 41: France 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• GERMANY
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 42: Germany Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 43: Germany 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 44: Germany Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Germany 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• ITALY
  • TABLE 46: Italy Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Italy 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 48: Italy Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 49: Italy 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• UNITED KINGDOM
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 50: UK Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: UK 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 52: UK Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 53: UK 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 55: Rest of Europe 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Rest of Europe 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• ASIA-PACIFIC
  • Norovirus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Asia-Pacific 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Asia-Pacific 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Norovirus Diagnostics by Product - Rapid Test Kits, PCR Kits and ELISA-based Kits - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Rest of World 6-Year Perspective for Norovirus Diagnostics by Product - Percentage Breakdown of Value Sales for Rapid Test Kits, PCR Kits and ELISA-based Kits for the Years 2025 & 2030
  • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Norovirus Diagnostics by End-Use - Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 65: Rest of World 6-Year Perspective for Norovirus Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Labs End-Use and Clinics End-Use for the Years 2025 & 2030

IV. COMPETITION